Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling...
Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Objectives
Multi-drug resistance (MDR) to chemotherapy is the main obstacle influencing the anti-tumor effect in breast cancer, which might lead to the metastasis and recurrence of cancer. Until now, there are still no effective methods that can overcome MDR. In this study, we aimed to investigate the role of sphingomyelin synthase 2 (SMS2) in b...
Alternative Titles
Full title
Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10824874
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10824874
Other Identifiers
ISSN
1432-1335,0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-023-05589-y
